277 related articles for article (PubMed ID: 27208742)
1. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
[TBL] [Abstract][Full Text] [Related]
2. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
3. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2--An Imperative Prognostic Biomarker in Oral Squamous Cell Carcinoma--An Immunohistochemical Study.
Byatnal AA; Byatnal A; Sen S; Guddattu V; Solomon MC
Pathol Oncol Res; 2015 Sep; 21(4):1123-31. PubMed ID: 25962348
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
Kumar M; Srivastava G; Kaur J; Assi J; Alyass A; Leong I; MacMillan C; Witterick I; Shukla NK; Thakar A; Duggal R; Roychoudhury A; Sharma MC; Walfish PG; Chauhan SS; Ralhan R
J Transl Med; 2015 Jan; 13():8. PubMed ID: 25591983
[TBL] [Abstract][Full Text] [Related]
6. High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.
Kidani K; Osaki M; Tamura T; Yamaga K; Shomori K; Ryoke K; Ito H
Oral Oncol; 2009 Jan; 45(1):39-46. PubMed ID: 18619895
[TBL] [Abstract][Full Text] [Related]
7. MUC4: a novel prognostic factor of oral squamous cell carcinoma.
Hamada T; Wakamatsu T; Miyahara M; Nagata S; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Int J Cancer; 2012 Apr; 130(8):1768-76. PubMed ID: 21618516
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic accumulation of activated leukocyte cell adhesion molecule is a predictor of disease progression and reduced survival in oral cancer patients.
Sawhney M; Matta A; Macha MA; Kaur J; DattaGupta S; Shukla NK; Ralhan R
Int J Cancer; 2009 May; 124(9):2098-105. PubMed ID: 19142865
[TBL] [Abstract][Full Text] [Related]
9. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Leusink FK; Koudounarakis E; Frank MH; Koole R; van Diest PJ; Willems SM
BMC Cancer; 2018 Apr; 18(1):385. PubMed ID: 29618339
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of p62/SQSTM1 subcellular localization and LC3B in oral squamous cell carcinoma.
Liu JL; Chen FF; Lung J; Lo CH; Lee FH; Lu YC; Hung CH
Br J Cancer; 2014 Aug; 111(5):944-54. PubMed ID: 24983366
[TBL] [Abstract][Full Text] [Related]
14. Caveolin 1 (Cav-1) and actin-related protein 2/3 complex, subunit 1B (ARPC1B) expressions as prognostic indicators for oral squamous cell carcinoma (OSCC).
Auzair LB; Vincent-Chong VK; Ghani WM; Kallarakkal TG; Ramanathan A; Lee CE; Rahman ZA; Ismail SM; Abraham MT; Zain RB
Eur Arch Otorhinolaryngol; 2016 Jul; 273(7):1885-93. PubMed ID: 26138391
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
16. Stromelysin-3 expression is an early event in human oral tumorigenesis.
Soni S; Mathur M; Shukla NK; Deo SV; Ralhan R
Int J Cancer; 2003 Nov; 107(2):309-16. PubMed ID: 12949813
[TBL] [Abstract][Full Text] [Related]
17. Cytoplasmic expression of SOX9 as a poor prognostic factor for oral squamous cell carcinoma.
Sumita Y; Yamazaki M; Maruyama S; Abé T; Cheng J; Takagi R; Tanuma JI
Oncol Rep; 2018 Nov; 40(5):2487-2496. PubMed ID: 30132562
[TBL] [Abstract][Full Text] [Related]
18. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of oral squamous cell carcinoma arising from oral epithelial dysplasia: rationale for monitoring premalignant oral lesions in a multidisciplinary clinic.
Ho MW; Field EA; Field JK; Risk JM; Rajlawat BP; Rogers SN; Steele JC; Triantafyllou A; Woolgar JA; Lowe D; Shaw RJ
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):594-9. PubMed ID: 23601832
[TBL] [Abstract][Full Text] [Related]
20. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]